Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
02/2008
02/19/2008US7332497 Pyrazolopyrimidines as therapeutic agents
02/19/2008US7332471 Cross-linked glycopeptide-cephalosporin antibiotics
02/19/2008US7332335 Increasing expression of p21WAF1/Cip 1 in cells to decrease proliferation of the cells by decreasing levels of PP5 protein in the cells.
02/14/2008WO2008019356A2 Process for the preparation of substituted-1,2,3,4-tetrahydroisoquinoline derivates
02/14/2008US20080039520 Anti-first-pass effect compounds
02/14/2008US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease
02/14/2008US20080039448 viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease; e.g. 1,1'[[(Propane-1,3-diyl)dioxy]bis(11aS)-11-sulpho-7-methoxy-2-methylidene-1,2,3,10,11,11a-hexahydro-5H-pyrrolo[2,1-c][1,4-benzodiazepin-5-one]] sodium salt
02/13/2008EP1885364A1 Halogenated quindoline dimers for the treatment of cancer
02/13/2008EP1689748B1 Novel 8-(piperazine-1-yl)- and 8-( 1,4 diazepan-1-yl)-xanthine, the production and use thereof in the from of a drug
02/12/2008US7329896 Polymerizable charge transport compounds
02/12/2008US7329751 Process for the preparation of clopidogrel
02/12/2008US7329663 Substituted-triazolopyrimidines as anticancer agents
02/12/2008CA2227695C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
02/07/2008WO2008015270A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
02/07/2008WO2008015269A1 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine
02/07/2008US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative
02/07/2008CA2659876A1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
02/06/2008EP1339712B1 3-substituted quinuclidines and their use as nicotinic agonists
02/06/2008CN100366624C 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
02/05/2008US7326709 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder
02/05/2008US7326702 antibiotics, fungicides, viricides; treating microbial infections; fused rings based on 1,4-benzoxazino(2,3,4-ij)quinolin-4-one for example
02/05/2008CA2383315C New derivatives of pyrimidin-4-ones, the process for the preparation thereof and the pharmaceutical compounds that contain them
02/05/2008CA2276613C Photoactivatable nitrogen-containing bases based on .alpha.-amino ketones
01/2008
01/31/2008WO2008012622A2 Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
01/31/2008WO2008012571A1 Imidazothiazole derivatives as mark inhibitors
01/31/2008WO2008011957A1 Substituted benzodithiophenes and benzodiselenophenes
01/31/2008WO2008011805A1 Vinblastines compounds, the preparation and the pharmaceutical use thereof
01/31/2008US20080027069 Quinazoline compounds
01/31/2008CA2658627A1 Imidazothiazole derivatives as mark inhibitors
01/30/2008EP1881827A1 Fused thiazole derivatives as kinase inhibitors
01/30/2008CN101115760A Pyrrolopyrazoles, potent kinase inhibitors
01/30/2008CN100364997C Vinorelbine preparation method
01/30/2008CN100364996C Purification method of catharanthine and vincristine
01/29/2008US7323484 Farnesyl transferase inhibitors
01/24/2008WO2008009700A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
01/24/2008WO2008009122A1 Acrylamide derivatives as fab i inhibitors
01/24/2008CA2658506A1 Acrymalide derivatives as fab 1 inhibitors
01/24/2008CA2658261A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
01/24/2008CA2657821A1 Aza-peptide protease inhibitors
01/23/2008EP1879901A1 Pyrrolobenzodiazepines
01/23/2008CN101108859A Vinblastine compound, method of preparing the same and use in medicament thereof
01/23/2008CN100363365C Immunomodulating heterocyclic compounds
01/17/2008WO2008008480A2 Nitroheteroaryl-containing rifamycin derivatives
01/17/2008WO2008006648A1 Substituted 1-methyl-1h-quinolin-2-ones and 1-methyl-1h-1,5-naphthyridin-2-ones as antibacterials
01/17/2008WO2007131020A3 Constrained compounds as cgrp-receptor antagonists
01/17/2008US20080015215 Diamine derivatives
01/16/2008EP1878734A1 Novel lactam compound
01/16/2008EP1532154B1 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
01/15/2008US7318966 Luminescent element material and luminescent element comprising the same
01/15/2008CA2476004C A novel method for total synthesis of ciguatoxin ctx3c class
01/15/2008CA2335514C Alkyl ether analogs of chlorins having an n-substituted imide ring
01/10/2008WO2008003766A2 4-heter0cycl0alkylpyri(mi)dines, process for the preparation thereof and their use as medicaments
01/10/2008WO2008003736A1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition
01/10/2008WO2008003690A1 Azatricyclic compounds and their use
01/10/2008CA2656905A1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition
01/10/2008CA2654670A1 New compounds
01/09/2008EP1876180A2 Semi-synthetic ecteinascidins
01/09/2008EP1874772A1 Purine and imidazopyridine derivatives for immunosuppression
01/09/2008EP1315729B1 Compounds in the form of homodimeric or heterodimeric prodrugs; process for obtaining these prodrugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterases-mediated diseases or dysfunction
01/09/2008CN100360532C Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
01/08/2008US7317010 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
01/08/2008US7316917 Production of bicyclic-heteroaryl-2-carboxylic acids by selective enzymatic hydrolysis of a mixture of positional esters
01/03/2008WO2008001182A1 Tricyclic heteroaryl compounds as pde10 inhibitors
01/03/2008WO2008001076A1 Fused thiazole derivatives as kinase inhibitors
01/03/2008US20080004307 Azaindoles Having Serotonin Receptor Affinity
01/03/2008US20080004293 Adenosine receptor antagonists and methods of making and using the same
01/03/2008CA2654394A1 Tricyclic heteroaryl compounds as pde10 inhibitors
01/02/2008EP1871376A2 Inhibitors of akt activity
01/01/2008US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation
01/01/2008US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases
01/01/2008US7314883 (+-)-3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carbonyl]-amino}-propionic acid to treat neurogenic vasodilation, neurogenic inflammaton, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases
01/01/2008US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents
01/01/2008US7314871 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension
12/2007
12/27/2007WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/27/2007WO2007147829A1 Azolopyrimidine compounds and their use for controlling harmful fungi
12/27/2007WO2007147346A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof
12/27/2007WO2007127175A3 Pharmaceutical compounds
12/27/2007WO2007072158A3 Pyrimidine derivatives for the treatment of abnormal cell growth
12/27/2007US20070299058 Anxiolytic Agents With Reduced Sedative And Ataxic Effects
12/27/2007CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/26/2007EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007EP1187835B1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
12/26/2007CN101094854A Constrained compounds as cgrp-receptor antagonists
12/26/2007CN100357296C Method for processing production raw materials of vinca alkaloid
12/25/2007US7312341 Kinase inhibitors; rheumatic diseases; antiarthritic agents
12/25/2007US7312212 Bactericides for infrections in man
12/21/2007WO2007144370A1 New chemical compounds
12/21/2007CA2654212A1 New chemical compounds
12/19/2007EP1866310A1 2,3-substituted fused pyrimidin-4(3h)-ones as vr1 antagonists
12/19/2007EP1771450B1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
12/19/2007EP1592426B1 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
12/19/2007CN101090902A Cgrp受体拮抗剂 Cgrp receptor antagonists
12/19/2007CN100355755C Diazabicyclic central nervous system active agents
12/18/2007US7309790 Chemical compounds
12/13/2007WO2007142216A1 Organic electroluminescent device and material for organic electroluminescent device
12/13/2007WO2007105154A3 Antibiotic compounds
12/13/2007WO2007064797A3 Inhibitors of c-met and uses thereof
12/13/2007US20070287836 Method for Preparing Compounds Comprising Cucurbituril Groups
12/12/2007EP1682545B1 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
12/12/2007EP1399443B1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 111